Hadassah

BioDesign Hadassah-Hebrew University Team Invents Solution to Surgical Problem

Monday, Feb 29 2016

Providing a solution for the bending of guide wires during spinal fusions and surgeries for a fractured hip or pelvis, a multidisciplinary team from the Hadassah Medical Center and Hebrew University’s BioDesign Medical Innovation program has invented an opto-electronic system called BendGuide that enables the surgeon to correct the problem as it occurs.

These thin metallic guide wires are important for the proper positioning of the fixation screws, which hold the bone in a fixed position. BendGuide monitors and detects minute changes in the guide wire’s trajectory during surgery and alerts the surgeon, in real time, to any deflection (bending). This enables a surgeon to make changes in the trajectory before damage occurs, eliminating breakage and the need for time-consuming repair. As Prof. Meir Liebergall, head of Hadassah’s Orthopedics Department, explains: “Complication in guide-wire positioning can lead to revision surgeries and increased hospitalization time and cost.” To address this surgical challenge, Prof. Liebergall partnered with a BioDesign team, comprised of medical doctors and engineering and business students.

BioDesign Medical Innovation is a multi-disciplinary, team-based approach to medical innovation, created by Hadassah and the Hebrew University. Sponsored by Boston Scientific and the Terumo Medical Corporation, the program brings together outstanding medical fellows, along with bioengineering and business graduate students, and tutors them in the science and practice of taking a medical innovation to market. The program is headed by Prof. Yaakov Nahmias, Director of the Hebrew University’s Alexander Grass Center for Bioengineering, and Prof. Chaim Lotan, Director of Hadassah’s Heart Institute.

The innovations produced by the Biodesign program participants are commercialized by Hadasit, the technology transfer company of the Hadassah Medical Center, and Yissum, the technology transfer company of the Hebrew University.

Comments

No comments yet.
First Name
Email
Comment
Enter this word:

Related Stories

alt_text

Wednesday, Aug 16 2017

Gazan Boy Walks for First Time at Hadassah

Unable to stand on his feet, suffering from severe respiratory distress, a four-year-old boy from Gaza gained the ability to walk once Hadassah Hospital surgeons identified and removed a large tumor lodged in his chest.

READ MORE ›
alt_text

Wednesday, Aug 16 2017

Hadassah Hosts Health Innovation Conference

Over one hundred doctors, researchers, and entrepreneurs gathered at Hadassah Hospital Ein Kerem this summer to discuss how to advance the quality of patient care with computational power.

READ MORE ›
alt_text

Monday, Aug 14 2017

Hadassah Hosts First Human Trial with Drug to Fight Nasty Bacterial Infection

Immuron, an Australian biopharmaceutical company, has received approval from the Hadassah Medical Organization’s ethics committee and Israel’s Ministry of Health to begin its first clinical trial with a new drug to fight a bacterial infection called Clostridium Difficile (CDI).

READ MORE ›
alt_text

Thursday, Aug 3 2017

Mystery of Devastating Pediatric Disease Solved by Hadassah Team

A genetic mutation causing a rare and devastating pediatric neurological disease that has puzzled medical centers around the world has been identified at the Hadassah Medical Organization by Prof. Orly Elpeleg, head of Hadassah's Department of Genetics and Metabolic Diseases.

READ MORE ›

Donation Questions

donorservices@hadassah.org

(800) 928-0685

Membership Questions

membership@hadassah.org

(800) 664-5646

Missions Department

missions@hadassah.org

(800) 237-1517

Contact Us

40 Wall Street

New York, NY 10005

support@hadassah.org

More ›

Show More